Chest Rub

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of cough due to the common cold when applied to the chest and throat. Additionally, it is indicated for the temporary relief of minor aches and pains when applied to muscles and joints.

Limitations of Use: There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, a thick layer of the product should be applied to the chest and throat, or directly onto sore, aching muscles. If desired, the area may be covered with a warm, dry cloth to enhance the effect. It is recommended to keep clothing loose around the throat and chest to facilitate the release of vapors to the nose and mouth. This application may be repeated up to three times within a 24-hour period, or as directed by a healthcare professional.

For children under 2 years of age, it is advised to consult a doctor before use.

Contraindications

The product is contraindicated for oral administration. It should not be applied with tight bandages, in the nostrils, or on wounds or damaged skin. These restrictions are in place to prevent potential adverse effects associated with improper use.

Warnings and Precautions

For external use only; direct contact with the eyes must be avoided to prevent irritation or injury.

In the event of accidental ingestion, it is imperative to seek immediate medical assistance or contact a Poison Control Center. Prompt action is essential to mitigate potential adverse effects.

Healthcare professionals should advise patients to discontinue use and consult a physician if muscle aches and pains persist for more than 7 days or if they recur. Additionally, patients should be instructed to stop use and seek medical advice if a cough lasts longer than 7 days, returns, or is accompanied by fever, rash, or a persistent headache, as these symptoms may indicate a serious underlying condition.

Emergency medical help should be sought without delay in cases of accidental ingestion, reinforcing the importance of immediate intervention in such scenarios.

Side Effects

Patients should be aware that the product is for external use only and should avoid contact with the eyes. In the event of persistent muscle aches and pains lasting more than 7 days or recurring, patients are advised to discontinue use and consult a healthcare professional. Additionally, if a cough persists for more than 7 days, returns, or is accompanied by fever, rash, or a persistent headache, it may indicate a serious condition, and medical advice should be sought.

Before using the product, patients should consult a doctor if they have a cough that produces excessive phlegm (mucus) or if they experience a persistent or chronic cough associated with conditions such as smoking, asthma, or emphysema.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Chest Rub (camphor, eucalyptus oil, menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a healthcare professional before use. For children aged 2 years and older, the recommended application involves rubbing a thick layer on the chest and throat or on sore, aching muscles. It is advised to cover the area with a warm, dry cloth if desired and to keep clothing loose around the throat and chest to facilitate the inhalation of vapors. This application may be repeated up to three times within a 24-hour period or as directed by a healthcare provider.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and maternal health. Healthcare providers can offer guidance tailored to individual circumstances, ensuring the safety of both the patient and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the insert text. Therefore, healthcare professionals should exercise caution and consider individual patient factors when prescribing to patients with reduced kidney function. Regular monitoring of renal function may be warranted in these patients, although specific guidelines are not outlined.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to monitor patients closely for any unusual symptoms or adverse effects that may arise following administration.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Patients should be evaluated for potential complications, and appropriate interventions should be implemented based on the clinical presentation.

Healthcare professionals are encouraged to report any cases of suspected overdosage to the relevant authorities to contribute to the ongoing assessment of the medication's safety profile.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of accidental ingestion of the product. It is important to instruct patients not to use the product by mouth, as it is intended for external use only.

Patients should be informed that the product should not be used in conjunction with tight bandages, in the nostrils, or on wounds or damaged skin. They should be counseled to discontinue use and consult a doctor if muscle aches and pains persist for more than 7 days or if they recur. Additionally, patients should be advised to stop using the product and seek medical advice if a cough lasts longer than 7 days, returns, or is accompanied by fever, rash, or a persistent headache, as these symptoms may indicate a serious condition.

When using this product, patients must be cautioned against heating it, microwaving it, or adding it to hot water or any container that involves heating water, as this may cause splattering and result in burns. Furthermore, patients should be encouraged to consult a doctor before using the product if they have a cough that produces excessive phlegm (mucus) or if they experience a persistent or chronic cough associated with smoking, asthma, or emphysema.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers assigned for identification. It is essential to adhere to the recommended storage conditions to ensure product integrity and efficacy.

The product should be stored at controlled room temperature, typically between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). It is crucial to protect the product from light and moisture, and it should be kept in its original container until use to maintain stability.

Healthcare professionals are advised to handle the product with care, following all safety guidelines to prevent any adverse effects. Failure to comply with these warnings could result in serious consequences.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Chest Rub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)